Article
Identification of APC Mutation as a Potential Predictor for Immunotherapy in Colorectal Cancer
13 Jul 2022
Abstract excerpt
To date, anticancer immunotherapy has presented some clinical benefits to most of advanced mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) colorectal cancer (CRC) patients. In addition to MSI status, we aimed to reveal the potential predictive value of adenomatous polyposis coli (APC) gene mutations in CRC patients. A total of 238 Chinese CRC patients was retrospectively identified and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
